Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pesek

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of Food Protection|April 18, 2019
Poultry Meat Irradiation - Effect of Temperature on Chemical Changes and Inactivation of MicroorganismsT Hanis, P Jelen, P Klír, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|August 1, 1986
[The importance of and basis for extensive resection in the surgical treatment of lung cancer]M Pesek, L Melínová, S Cermák, et al.
Sbornik Lekarsky|February 1, 1979
[Changes of pulmonary functions and subsequent life of patients indicated to plumonary resection for bronchogenic carcinoma--long-term investigation (author's transl)]M Navrátil, M Pesek, J Lichtenberg, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|March 1, 1979
[Recurrencies in patients with lung cancer following radical resection]H Mostecký, J Lichtenberg, M Pesek, et al.
Neoplasma|April 16, 2013
Comparison of EGFR-TKI and chemotherapy in the first-line treatment of advanced EGFR mutation-positive NSCLCO Fiala, M Pesek, J Finek, et al.
Cancer Genomics & Proteomics|April 27, 2011
Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplificationJ Krejci, M Pesek, P Grossmann, et al.
Neoplasma|December 25, 2012
Second line treatment in advanced non-small cell lung cancer (NSCLC): comparison of efficacy of erlotinib and chemotherapyO Fiala, M Pesek, J Finek, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|June 1, 1984
[Personal experience with the surgical treatment of lung cancer from 1962 to 1982]J Fanta, J Lichtenberg, M Pesek, et al.
Neoplasma|October 17, 2012
Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practiceO Fiala, M Pesek, J Finek, et al.
Anticancer Research|August 19, 2007
Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancerJ Safranek, L Holubec, O Topolcan, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Food Protection|April 18, 2019
Poultry Meat Irradiation - Effect of Temperature on Chemical Changes and Inactivation of MicroorganismsT Hanis, P Jelen, P Klír, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|August 1, 1986
[The importance of and basis for extensive resection in the surgical treatment of lung cancer]M Pesek, L Melínová, S Cermák, et al.
Sbornik Lekarsky|February 1, 1979
[Changes of pulmonary functions and subsequent life of patients indicated to plumonary resection for bronchogenic carcinoma--long-term investigation (author's transl)]M Navrátil, M Pesek, J Lichtenberg, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|March 1, 1979
[Recurrencies in patients with lung cancer following radical resection]H Mostecký, J Lichtenberg, M Pesek, et al.
Neoplasma|April 16, 2013
Comparison of EGFR-TKI and chemotherapy in the first-line treatment of advanced EGFR mutation-positive NSCLCO Fiala, M Pesek, J Finek, et al.
Cancer Genomics & Proteomics|April 27, 2011
Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplificationJ Krejci, M Pesek, P Grossmann, et al.
Neoplasma|December 25, 2012
Second line treatment in advanced non-small cell lung cancer (NSCLC): comparison of efficacy of erlotinib and chemotherapyO Fiala, M Pesek, J Finek, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|June 1, 1984
[Personal experience with the surgical treatment of lung cancer from 1962 to 1982]J Fanta, J Lichtenberg, M Pesek, et al.
Neoplasma|October 17, 2012
Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practiceO Fiala, M Pesek, J Finek, et al.
Anticancer Research|August 19, 2007
Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancerJ Safranek, L Holubec, O Topolcan, et al.
Pageof 6